Re-engineering the post-myocardial infarction medicines optimisation pathway: a retrospective analysis of a joint consultant pharmacist and cardiologist clinic model
Crossref DOI link: https://doi.org/10.1136/openhrt-2018-000921
Published Online: 2018-12-10
Published Print: 2018-12
Update policy: https://doi.org/10.1136/crossmarkpolicy
Khatib, Rani
Patel, Nasrin
Laverty, Una
Mcgawley, Gina
McLenachan, Jim
Shield, Sarah
Hall, Alistair S
Funding for this research was provided by:
AstraZeneca (Initial proof of concept was partially funded)
